Intro

This chapter explores current tariff discussions and presidential initiatives focused on boosting domestic pharmaceutical manufacturing in the U.S. It also features an earnings report from AstraZeneca, underlining its stock performance and insights from the CEO about the company's role in the industry.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app